Retrospective analysis of liraglutide and basal insulin combination therapy in Japanese type 2 diabetes patients: The association between remaining β‐cell function and the achievement of the glycated hemoglobin target 1 year after initiation

AIMS/INTRODUCTION: The glucose‐lowering effects of the glucagon‐like peptide‐1 receptor agonist, liraglutide, have been shown to rely on remaining β‐cell function. However, the possible associations of remaining β‐cell function with the glucose‐lowering effects of liraglutide in combination with bas...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Diabetes Investig
Autors principals: Usui, Ryota, Sakuramachi, Yui, Seino, Yusuke, Murotani, Kenta, Kuwata, Hitoshi, Tatsuoka, Hisato, Hamamoto, Yoshiyuki, Kurose, Takeshi, Seino, Yutaka, Yabe, Daisuke
Format: Artigo
Idioma:Inglês
Publicat: John Wiley and Sons Inc. 2017
Matèries:
Articles
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6031501/
https://ncbi.nlm.nih.gov/pubmed/29106046
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jdi.12773
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars